---
document_datetime: 2023-09-21 18:02:29
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/trevicta-previously-paliperidone-janssen-epar-all-authorised-presentations_en.pdf
document_name: trevicta-previously-paliperidone-janssen-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.934276
conversion_datetime: 2025-12-26 10:28:36.199779
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                        | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                        |
|------------------|-------------------|------------|--------------------------------------------|---------------------------|-----------------------|---------------------------|----------------------------------|
| EU/1/14/971/007  | Trevicta          | 175mg      | Prolonged-release suspension for injection | Intramuscular use         | pre-filled syringe    | 0.875 ml (200 mg/ml)      | 1 pre-filled syringe + 2 needles |
| EU/1/14/971/008  | Trevicta          | 263mg      | Prolonged-release suspension for injection | Intramuscular use         | pre-filled syringe    | 1.315 ml (200 mg/ml)      | 1 pre-filled syringe + 2 needles |
| EU/1/14/971/009  | Trevicta          | 350mg      | Prolonged-release suspension for injection | Intramuscular use         | pre-filled syringe    | 1.750 ml (200 mg/ml)      | 1 pre-filled syringe + 2 needles |
| EU/1/14/971/010  | Trevicta          | 525mg      | Prolonged-release suspension for injection | Intramuscular use         | pre-filled syringe    | 2.625 ml (200 mg/ml)      | 1 pre-filled syringe + 2 needles |